AstraZeneca Says 2027 Readouts Have More Than Twenty Billion Dollars in Potential
AstraZeneca said its upcoming 2027 readouts have potential exceeding twenty billion dollars.
AstraZeneca said its upcoming 2027 readouts have potential exceeding twenty billion dollars.